Skin Inflammation in Human Health and Disease

Course Overview

This course will focus on skin and its role in human health and disease. The speakers will present the most recent findings that better our understanding the role of human skin as a barrier, immunologic organ, and readily accessible avenue for drug delivery. Cutting edge research techniques and strategies will be discussed that can be applied by investigative dermatologists looking to develop new directions in research. Research findings that can be applied to clinical practice will be discussed and emphasized. By the end of this conference, participants will have an improved understanding of the complex relationship between the immune system and the skin. 

The course will begin on Wednesday, June 25, at 7:00pm with a two-hour poster session. Entrants will be chosen in advance based upon abstracts submitted prior to the conference. The bulk of the conference will be held on Thursday and Friday. Topics that will be covered will include: The role of the innate and adaptive immune system in skin immunity, Skin as a barrier, Interplay between the skin and microbiome, Emerging therapeutics in Skin Disease, and Emerging Technologies for human skin disease research. Information will be presented in lecture format with a brief period for questions and answers following each presentation. Speakers are a diverse group of leading faculty from regional, national, and international institutions who will provide a broad field of discourse on both the basic science and clinical implications of the most recent research in cutaneous immunology.

Who Should Attend

• Dermatologists

Learning Objectives

Upon completion of this activity, participants will be able to:

• Summarize the recent advances in inflammatory skin diseases which will help physicians achieve better outcomes.
• Recognize appropriate management and treatment options for inflammatory skin diseases and utilize these approaches in routine clinical practice. 
• Clarify the basic biology of inflammatory skin disease so that participants will be able to select evidence-based treatment regimens and apply recent clinical evidence to selection of treatment for different inflammatory skin diseases. 
• Communicate the biology of skin disorders so that participants will be able to more effectively convey the biology of the disease to patients, enhancing understanding and treatment compliance.